Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neothetics (NEOT)

Neothetics (NEOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,592
  • Shares Outstanding, K 13,850
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,020 K
  • 60-Month Beta 3.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.49
Trade NEOT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/09/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.55 +23.87%
on 12/18/17
2.15 -10.70%
on 01/04/18
+0.28 (+17.07%)
since 12/15/17
3-Month
1.03 +86.41%
on 10/24/17
2.15 -10.70%
on 01/04/18
+0.20 (+11.63%)
since 10/17/17
52-Week
0.30 +540.00%
on 09/07/17
2.63 -27.00%
on 05/25/17
+0.74 (+62.71%)
since 01/17/17

Business Summary

Neothetics, Inc. is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The Company is focused on localized fat reduction and body contouring. Its lead product candidate, LIPO-202, is for the reduction of central abdominal bulging due to subcutaneous fat...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 2.00
1st Resistance Point 1.96
Last Price 1.92
1st Support Level 1.86
2nd Support Level 1.80
3rd Support Level N/A

See More

52-Week High 2.63
Last Price 1.92
Fibonacci 61.8% 1.74
Fibonacci 50% 1.47
Fibonacci 38.2% 1.19
52-Week Low 0.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar